Trial NCT04431466

View at ClinicalTrials.gov 
Org. Study IDs: IFORS

Last trial update was posted on 2021-10-12

MeSH Interventions

Ivermectin

MeSH Conditions

Coronavirus Infections Infections

Other Conditions

Coronavirus Infection

Stopping Reasons

Preliminary data from a pilot study suggest that the administration of ivermectin in patients with SARS-CoV-2 is safe, reducing symptoms and viral load. The antiviral effects of ivermectin appear to depend on the dose administered.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID